Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
48.48
+2.45 (5.32%)
At close: Jul 17, 2026, 4:00 PM EDT
47.73
-0.75 (-1.55%)
After-hours: Jul 17, 2026, 7:23 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $3.45 billion as of July 17, 2026. Its market cap has increased by 205.54% in one year.
Market Cap
3.45B
Enterprise Value
1.99B
1-Year Change
205.54%
Ranking
Category
Stock Price
$48.48
ChartMarket Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $3.45B, an increase of 527.83%. That is a compound annual growth rate of 70.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 3.45B | -28.34% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyne Therapeutics | 3.97B |
| Catalyst Pharmaceuticals | 3.85B |
| Telix Pharmaceuticals | 3.81B |
| Parabilis Medicines | 3.81B |
| NewAmsterdam Pharma Company | 3.74B |
| Enliven Therapeutics | 3.71B |
| Alumis | 3.67B |
| Denali Therapeutics | 3.65B |